Special Report

Bayer expects closing of Monsanto purchase by end of year

 

David Hollinrake, Vice President of Marketing for Bayer Crop Science North America tells Brownfield his company has a long term strategy.  With eyes on 2030, Bayer is investing in innovation and long-term business development which includes the purchase of Monsanto.  Closing on that purchase is expected by the end of the year.

Monsanto, Hollinrake explains, is really good at biology and biotechnology and building a data platform.  Bayer is very successful in crop chemistry.  He believes bringing those complimentary capabilities and geography together will spur innovation to help farmers better do what they do.

Bayer Crop Science invests 1.1 billion dollars annually in agriculture research globally.  Hollinrake tells Brownfield that bringing Bayer and Monsanto together will increase investment and opportunity in research and development of complimentary products and services.

Brownfield interviewed Hollinrake during the 2017 Bayer AgVocacy Forum held prior to Commodity Classic. Research Bayer has conducted shows the most trusted voice relative to where and how food is grown is the American Farmer.  Hollinrake is passionate about his company’s efforts to help farmers be more confident in engaging with consumers.

Conversation with David Hollinrake: